These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21392859)

  • 1. Synthesis and biological evaluation of dibenz[b,f][1,5]oxazocine derivatives for agonist activity at κ-opioid receptor.
    Mitra S; Banerjee TS; Hota SK; Bhattacharya D; Das S; Chattopadhyay P
    Eur J Med Chem; 2011 May; 46(5):1713-20. PubMed ID: 21392859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.
    Ohnmacht CJ; Albert JS; Bernstein PR; Rumsey WL; Masek BB; Dembofsky BT; Koether GM; Andisik DW; Aharony D
    Bioorg Med Chem; 2004 May; 12(10):2653-69. PubMed ID: 15110847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-one as a structurally new NK1 antagonist.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1485-8. PubMed ID: 15713412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
    Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
    Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palladium-mediated intramolecular aryl amination on furanose derivatives: an expedient approach to the synthesis of chiral benzoxazocine derivatives and tricyclic nucleosides.
    Neogi A; Majhi TP; Mukhopadhyay R; Chattopadhyay P
    J Org Chem; 2006 Apr; 71(8):3291-4. PubMed ID: 16599633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of crucial structural requirements of 2-substituted pyrimido[4,5-b][1,5]oxazocines as NK(1) receptor antagonist by axially chiral derivatives.
    Seto S; Asano J
    Bioorg Med Chem; 2007 Aug; 15(15):5083-9. PubMed ID: 17540575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.
    Kumar V; Guo D; Marella M; Cassel JA; Dehaven RN; Daubert JD; Mansson E
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3667-71. PubMed ID: 18487043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2H-pyrido[4,3-b]- and [2,3-b]-1,5-oxazocin-6-ones as NK(1) antagonists.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1479-84. PubMed ID: 15713411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability.
    Park HS; Lee HY; Kim YH; Park JK; Zvartau EE; Lee H
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3609-13. PubMed ID: 16650985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.
    Tsou HR; Overbeek-Klumpers EG; Hallett WA; Reich MF; Floyd MB; Johnson BD; Michalak RS; Nilakantan R; Discafani C; Golas J; Rabindran SK; Shen R; Shi X; Wang YF; Upeslacis J; Wissner A
    J Med Chem; 2005 Feb; 48(4):1107-31. PubMed ID: 15715478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity.
    Rocha FV; Barra CV; Netto AV; Mauro AE; Carlos IZ; Frem RC; Ananias SR; Quilles MB; Stevanato A; da Rocha MC
    Eur J Med Chem; 2010 May; 45(5):1698-702. PubMed ID: 20116142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azepinone as a conformational constraint in the design of kappa-opioid receptor agonists.
    Tuthill PA; Seida PR; Barker W; Cassel JA; Belanger S; DeHaven RN; Koblish M; Gottshall SL; Little PJ; DeHaven-Hudkins DL; Dolle RE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5693-7. PubMed ID: 15482950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes.
    Bollini M; Casal JJ; Bruno AM
    Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
    Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
    J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
    Shi C; Wang J; Chen H; Shi D
    J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A; Anzini M; Vomero S; Menziani MC; De Benedetti PG; Sbacchi M; Clarke GD; Mennuni L
    J Med Chem; 1996 Feb; 39(4):860-72. PubMed ID: 8632410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM; Traynor JR
    Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxic activity of benzo[a]acronycine and benzo[b]acronycine substituted on the A ring.
    Gaslonde T; Covello F; Velazquez-Alonso L; Léonce S; Pierré A; Pfeiffer B; Michel S; Tillequin F
    Eur J Med Chem; 2011 May; 46(5):1861-73. PubMed ID: 21411193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.